文章摘要
周振,冯国忠.从生产者角度分析药品临床供应短缺的原因[J].中国药事,2017,(6):596-599
从生产者角度分析药品临床供应短缺的原因
Analysis of the Causes of Shortage of Clinical Drug Supply from the Viewpoint of Manufacturers
投稿时间:2017-01-05  
DOI:10.16153/j.1002-7777.2017.06.002
中文关键词: 生产企业  药品短缺  利润  价格  原料获取  流通渠道  政策建议
英文关键词: manufacturers  drug shortage  proft  price  raw material acquisition  distribution channel  policy suggestions
基金项目:
作者单位E-mail
周振 中国药科大学国际医药商学院, 南京 211198  
冯国忠 中国药科大学国际医药商学院, 南京 211198 fenzhongcpu@126.com 
摘要点击次数: 793
全文下载次数: 487
中文摘要:
      目的:从生产者角度分析药品短缺原因,提出应对药品短缺问题的政策建议。方法:采用文献综述法和归纳总结法,分析药品短缺原因;在此基础上提出相关建议。结果与结论:对于药品生产企业来说,药品短缺原因分为生产原因和非生产原因。生产性原因分为主观原因和客观原因。主观原因主要有价格太低、需求量少、成本上升等造成企业不愿生产;客观原因主要有原料获取困难、生产条件不符合规定等。非生产性原因主要有流通环节利润太低、流通垄断、意外情况等。应进一步调动生产企业积极性、净化原料和流通环节、落实保障政策,提高相应药品的可及性。
英文摘要:
      Objective: To analyze the causes of drug shortage from the viewpoint of manufacturer and put forward policy suggestions to deal with the drug shortage. Methods: The causes of drug shortage were analyzed using methods of literature review and induction, and relevent suggestions were put forward. Results and Conclusion: As far as drug manufacturers are concerned, the causes of drug shortage are divided into production reasons which are divided into subjective reasons and objective reasons and non-production reasons which include low distribution proft, distribution monopoly, accidents and so on. The main subjective reasons include too low prices, low demand, as well as rising costs, with the result that manufacturers are unwilling to produce. The main objective reasons include the shortage of raw materials and the unqualifed requirements for production conditions. Government should further mobilize the enthusiasm of drug manufacturers, clarifcation of raw material market and distribution, implement security policies and other measures to improve the accessibility of the corresponding drugs.
查看全文   查看/发表评论  下载PDF阅读器
关闭